Navamedic ASA (OSL:NAVA)
Norway
· Delayed Price · Currency is NOK 22.90
+1.50 (7.01%)
Apr 1, 2025, 3:44 PM CET
Navamedic ASA Revenue
In the year 2024, Navamedic ASA had annual revenue of 531.44M NOK with 3.80% growth. Navamedic ASA had revenue of 131.20M in the quarter ending December 31, 2024, with 4.70% growth.
Revenue
531.44M
Revenue Growth
+3.80%
P/S Ratio
n/a
Revenue / Employee
11.81M
Employees
45
Market Cap
399.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 531.44M | 19.44M | 3.80% |
| Dec 31, 2023 | 512.00M | 129.86M | 33.98% |
| Dec 31, 2022 | 382.14M | 103.70M | 37.24% |
| Dec 31, 2021 | 278.44M | 68.56M | 32.67% |
| Dec 31, 2020 | 209.88M | 21.12M | 11.19% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 562.60M |
| Nordhealth AS | 537.23M |
| Photocure ASA | 525.39M |
| Vistin Pharma ASA | 429.50M |
| Hofseth BioCare ASA | 265.54M |
| Omda AS | 426.27M |
| ArcticZymes Technologies ASA | 108.11M |
| Nykode Therapeutics AS | 104.04M |